Lexaria Bioscience Corp (LEXX) stock is lower by -36.36% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives LEXX stock a score of 61 out of a possible 100.
That rank is mainly influenced by a long-term technical score of 90. LEXX's rank also includes a short-term technical score of 24.
LEXX has an Overall Score of 61. Find out what this means to you and get the rest of the rankings on LEXX!
Lexaria Bioscience Corp (LEXX) stock has risen 1.25% while the S&P 500 has gained 0.36% as of 12:45 PM on Wednesday, Nov 1. LEXX has gained $0.02 from the previous closing price of $1.38 on volume of 62,480 shares. Over the past year the S&P 500 is up 9.14% while LEXX is lower by -36.36%. LEXX lost -$1.13 per share in the over the last 12 months.
Click Here to get the full Stock Report for Lexaria Bioscience Corp stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter